Match Document Document Title
6284770 Medicaments for the treatment of non-constipated female irritable bowel syndrome  
This invention relates to the use of 5-HT3 receptor antagonists in the treatment of nonconstipated female IBS patients.
6277849 N-sulphonyl and N-sulphinyl amino acid amides as microbiocides  
The invention relates to novel pesticidally active compounds of the general formula I ##STR1## as well as possible isomers and isomeric mixtures thereof, wherein n is a number zero or one; and ...
6271256 Methods for controlling gram negative bacteria in mammals with bicyclo spiroether compounds  
Methods for controlling growth of gram negative bacteria, such as Helicobacter pylori, which are agents associated with disorders of the gastrointestinal tract of a mammal are described. They...
6271241 Cycloalkyl and aryl fused aminoalkyl-imidazole derivatives: modulators and GLP-1 receptors  
Disclosed are compounds of the formula: ##STR1## or the pharmaceutically acceptable non-toxic salts thereof wherein X, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , A, B, C, and D are variables defined...
6255331 Stable biocidal compositions  
Disclosed are biocidal compositions comprising mixtures of formaldehyde-releasing imidazolidines, such as 1,3-dimethylol-5,3-dimethylhydantoin, and 3-isothiazolones stabilized with low levels of...
6248768 Benzimidazole derivatives and pharmacologically acceptable salts thereof  
This invention provides a compound having both IL-4 production inhibitory activity and PDE (IV) inhibitory activity, represented by formula (I): ##STR1## and a pharmaceutical composition or a...
6235765 Benzimidazole derivatives  
Novel benzimidazole derivatives of the formula ##STR1## in which R 1 , R 2 , X 1 , X 2 , X 3 , X 4 and Y are each as defined in the description, and acid addition salts and metal salt...
6218388 Benzimidazoles for inhibiting protein tyrosine kinase mediated cellular proliferation  
Benzimidazoles of Formula I below are inhibitors of protein tyrosine kinases, and are useful in treating cellular proliferation. ##STR1## The compounds are especially useful in treating cancer,...
6214881 IL-8 receptor antagonists  
The present invention relates to the novel use of phenyl ureas in the treatment of disease states mediated by the chemokine, Interleukin-8 (I-8).
6207693 Benzamide derivatives having a vasopressin antagonistic activity  
This invention relates to new benzamide derivatives having a vasopressin antagonistic activity, etc. and represented by general formula (I): ##STR1## wherein R 1 is aryl optionally substituted...
6204264 Benzimidazole derivative, hair growth promoter and external composition for skin using the same  
A benzimidazole derivative or a salt thereof expressed by the following Formula (I): ##STR1## wherein one of A and B is a hydrocarbon group of C 10 -30 expressed by R 1 and the other is --(CH 2 )...
6204249 L-benzimidazole nucleosides  
The present invention relates to benzimidazole derivatives and their use in medical therapy particularly for the treatment or prophylaxis of virus infections such as those caused by herpes viruses....
6204282 Benzimidazole compounds that are vitronectin receptor antagonists  
The present invention provides compounds having the formula ##STR1## wherein n, p, q and r are each independently selected from 0 or 1; a, b, c, and d each independently represents a carbon...
6194396 Benzimidazole compounds as bradykinin antagonists  
This invention relates to a heterocyclic compound of the formula ##STR1## wherein a group of the formula: ##STR2## is a group of the formula ##STR3## X is O, S or N-R 5 , R 1 is lower...
6177454 Amide derivatives and medicinal compositions thereof  
An amide derivative represented by the following general formula (I) or a salt thereof and a pharmaceutical composition containing the amide derivative and a pharmaceutically acceptable vehicle....
6174910 AT1 receptor antagonist for the stimulation of apoptosis  
6169105 Potentiation of drug response  
The power of citalopram, fluvoxamine and paroxetine to increase the availability of sarotonin, norepinephrine and dopamine, particularly serotonin, is augmented by administration in combination...
6156779 Methods of combating infectious diseases using dicatoni bis-benzimidazoles  
The present invention provides methods for treating Cryptococcus neoformans and Candida albicans in a subject in need of such treatment. The methods comprises administering to the subject a...
6150371 Method for preventing and for treating autoimmune disease  
A method for preventing or treating autoimmune diseases (excluding type I diabetes) by administering an insulin resistance improving substance as an active ingredient.
6143788 Bis-amino acid hydroxyethlamino sulfonamide retroviral protease inhibitors  
Selected bis-amino acid hydroxyethylamino sulfonamide compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease. The present invention relates to...
6140355 Pharmaceutical compositions containing rifaximin for treatment of vaginal infections  
Vaginal pharmaceutical compositions administrable through the topical route, particularly in the form of foams and creams containing a therapeutically effective amount of rifaximin (Common...
6136836 Compositions for the systemic control of parasites of warm-blooded animals  
A composition and method for controlling warm-blooded animal parasites comprising 1-[3-chloro-4-(1,1,2-trifluoro-2-trifluoromethoxyethoxy)phen yl]-3-(2,6,dif luorobenzoyl)urea.
6136831 Pyrazole derivatives and COX inhibitors containing them  
The purpose is to provide anti-inflammatory agents which have potent pharmacological actions and exert a selective inhibitory activity on COX-2, thereby being expected to reduce adverse effects...
6127395 Substituted aryl and cycloalkyl imidazolones; a new class of GABA brain receptor ligands  
Disclosed are compounds of the formula: ##STR1## wherein: T is NH, O, or S; X is hydrogen, hydroxyl, lower alkyl, or an optionally substituted amide; the W ring is an optionally substituted...
6127380 4-aminoalkoxy-1H-benzoimidazoles  
This invention relates to D 2 dopaminergic compounds of the formula ##STR1## wherein: R 1 is hydrogen, trifluoromethyl, pentafluoroethyl, heptafluoropropyl, straight-chain or branched alkyl group...
6127389 Benzimidazole derivatives as bradykinin agonists  
This invention relates to compounds of formula: ##STR1## wherein R 6 , R 7 , R 2 , R 2 , R 3 and A 1 are as defined in the disclosure; and pharmaceutically acceptable salts thereof, to processes...
6123962 Process for producing stabilized pharmaceutical composition  
The pharmaceutical composition of the invention, which comprises a benzimidazole compound of the formula ##STR1## wherein R 1 is hydrogen, alkyl, halogen, cyano, carboxy, carboalkoxy,...
6114369 Benzimidazole compound  
6110967 Epoxysuccinamide derivative or salt thereof  
The invention relates an epoxysuccinamide derivative represented by a formula (I): ##STR1## wherein R 1 represents a hydrogen atom, an alkyl or aminoalkyl group, R 2 represents an aminoalkyl...
6110963 Aryl-oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia  
This invention provides compounds of Formula I having the structure ##STR1## wherein A is C or N; B is O, S, N, or CHCH; E is ##STR2## or --X--D; D is ##STR3## or alkyl of 1-12 carbon...
6103768 Fatty acid based compositions and methods for the control of plant infections and pests  
The invention described here concerns the unique utility of fatty acids and their derivatives to eradicate existing fungal and bacterial infections in plants. Also, described herein are combination...
6100252 Heterocyclic compounds and their use as angiotensin antagonists  
6096766 3-benzylaminopiperidines as tachykinin receptor antagonists  
6096755 N-substituted azabicycloalkane derivatives, their preparation and use  
Compounds of the formula I ##STR1## where B, R 1 , R 2 , n, R 3 , A, X, Y and Z have the meanings stated in the description, and their preparation are described. The novel compounds are suitable...
6083973 Methods for inhibiting mucin secretion using RAR α selective antagonists  
This invention provides methods of of inhibiting mucin production in a mammal comprising administering to the mammal an RAR antagonist. Preferably, the RAR antagonist is an RARα selective...
6071909 Phenylbenzimidazole derivatives as ligands for GABA receptors  
6071931 AT.sub.1 -receptor antagonists for preventing and treating postischemic renal failure and for protecting ischemic kidneys  
The compound (S)-N-(1-carboxy-2-methylprop-1-yl)-N-pentanoyl-N-[2'(1H-tet razol-5-yl)bip henyl-4-yl-methyl]amine (valsartan) of formula ##STR1## or a salt thereof, in particular a pharmaceutically...
6069126 Antifungal combination therapy  
There is described antifungal combination therapy comprising the use of known antifungal agents such as the azoles or polyenes in combination with a pneumocandin derivative antifungal agent. More...
6040327 Benzimidazole, benzoxazole and benzothiazole compounds  
A compound of formula (I): ##STR1## wherein: R 1 represents halogen or a different group as defined in the description, Ra and Rb, which mnay be identical or different, represent hydrogen,...
6034116 Mixtures of substituted benzimidazoles with polyether antibiotics or synthetic coccidiostats as agents for use against parasitic protozoa  
6030992 Methods of treating or preventing sleep apnea  
6017941 Method of combatting infectious diseases using dicationic bis-benzimidazoles  
The present invention provides methods for treating Cryptococcus neoformans and Candida albicans in a subject in need of such treatment. The methods comprises administering to the subject a...
6017923 Carbo-acyclic nucleoside derivatives as antiviral and antineoplastic agents  
6015827 Benzoxazole-4-carboxamides and their use in inhibiting poly (adp-ribose) polymerase activity and improving cytotoxic effectiveness of cytotoxic drugs or radiotherapy  
Benzoxazole carboxamides are disclosed which can act as potent inhibitors of the DNA repair enzyme poly(ADP-ribose) polymerase or PARP enzyme (EC 2.4.2.30), and which thereby can provide useful...
6013644 Spiro-substituted azacycles as modulators of chemokine receptor activity  
The present invention is directed spiro-substituted azacycles of formula I: (wherein R 1 , R 2 , R 3 , R 4 , R 5 , k, l and m are defined herein) which are useful as modulators of chemokine...
6001866 Method for treating and preventing inflammation and atherosclerosis  
This invention provides a method for treating or preventing inflammation or atherosclerosis in mammals comprising administering an effective amount of a 15-LO inhibitor of Formula I: ##STR1##...
5998398 2-amino-5,6-dichlorobenzimidazole derivatives having antiviral activity  
The present invention relates to benzimidazole derivatives of formula (I) wherein: R 1 represents H, C 1 -4 alkyl, C 3 -5 cycloalkyl; R 2 represents H, C 1 -4 alkyl; or R 1 and R 2 together...
5977154 Selective β3 adrenergic agonist  
The present invention is in the field of medicine, particularly in the treatment of Type II diabetes and obesity. More specifically, the present invention relates to selective β3 adrenergic...
5965565 Piperidines promote release of growth hormone  
The present invention is directed to certain piperidines, pyrrolidines, and hexahydro-1H-azepines of the general structural formula: ##STR1## wherein B is selected from: ##STR2## and R 1 , R 1a , R...
5962492 2 cyclo(alkyl and alkenyl) phenyl-alkenylyl heteroaryl compounds and pharmaceutical compositions containing same  
Compounds of general formula (1) ##STR1## are described wherein Y is a halogen atom or a group --OR 1 , wherein R 1 is an optionally substituted alkyl group; X is --O--, --S--, or --N(R 6 ),...